Family
Medicine Keywords Defined - 2005
Close
Window.
Medtext
keyword books give you an overview of the topics that
have been presented on the board exam during the
last couple of years. All keywords are defined and include
current references with page numbers.
Samples:
EN001 Adrenal
Insufficiency
Cortisol
is the predominant corticosteroid secreted from the adrenal
cortex in humans. Many diseases and treatments can interfere
with the normal corticosteroid response to illness and thus
induce tissue corticosteroid insufficiency. These etiologies
include, head injury, central nervous system depressants,
pituitary infarction, adrenal hemorrhage from septicemia and
coagulopathy, destruction of adrenal tissue by tumors or infection
such as HIV, or exogenous agents such as etomidate (anesthetic
agent), ketoconazole medroxyprogesterone, and megestrol acetate
treatment. Exogenous corticosteroid therapy in patients generally
receiving more than 30 mg. of hydrocortisone per day (7.5
mg of prednisolone or 0.75 mg of dexamethasone per day) for
more than three weeks can suppress the hypothalamic-pituitary-adrenal
axis and induce adrenal atrophy that may persist for months
after the cessation of corticosteroid treatment.
Features
of corticosteroid insufficiency include symptoms such as weakness,
anorexia, nausea, vomiting, abdominal pain, myalgia, arthralgia,
dizziness, headaches, memory impairment, depression, amenorrhea,
cold intolerance, and salt cravings. Findings on physical
exam may include postural hypotension, fever, tachycardia,
increased pigmentation, decreased body hair, and vitiligo.
Clinical problems include hyponatremia, hypoglycemia, hyperkalemia,
eosinophilia, elevated thyrotropin levels, hemodynamic instability,
and multiple-organ dysfunction.
Making
the diagnoses can be difficult but helpful laboratory measurements
include checking random cortisol levels and/or the cortisol
response to the corticotropin stimulation test.
Treatment
with corticosteroid during intercurrent and acute illnesses
for the adrenal insufficiency depends upon the extent to the
disease and the patient’s condition. Replacement doses
may be given for minor trauma, surgery or fever. Larger doses
need to be given for major surgery, major trauma, or critical
illness such as septic shock. For patients with persistent
adrenal deficiency, long-term hydrocortisone treatment ranging
from 15-25 mg per day is generally indicated. Many patients
with adrenal disease may also require mineralocorticoid replacement
with 0.05 to 0.2 mg of fludrocortisone per day. These patients
need to increase their doses during periods of acute illnesses,
stress, trauma, or surgery.
1.
Cooper, MS, and Stewart, PM. Corticosteroid Insufficiency
in Acutely Ill Patients. NEJM. 2003;348:727-34.
GE004 B12
Deficiency
Vitamin
B12 (cobalamin) has an important role in DNA synthesis and
neurologic function. The role it plays in hyperhomocysteinemia
and atherosclerosis is still being uncovered. Old ideas about
oral supplementation are now being shown to be not true.
The
true prevalence in the population of B12 deficiency is unknown.
Studies have shown that in patients over 65 the incidence
may be as high as 15%. The use of gastric acid blocking agents
can lead to decreased B12 levels.
Clinical
signs of B12 deficiency are hematologic, neurologic and psychiatric.
Hematologically you can see megaloblastic anemia and pancytopenia.
Neurologically paresthesias, peripheral neuropathy and combined
systems disease may be seen. Irritability, personality change,
mild memory impairment, dementia, depression and psychosis
may be some of the psychiatric changes seen. Now research
says that an increased risk of myocardial infarction and stroke
may be tied to B12 deficiency.
It
is felt that low B12 levels produce hyperhomocysteinemia which
is an independent risk factor for cardiovascular disease.
Only
two enzymatic reactions are known to be dependent on B12.
Methylmalonic acid is converted to succinyl-CoA using B12
as a cofactor. Low B12 results in increased levels of methylmalonic
acid. Secondly homocysteine is converted to methionine by
using B12 and folic acid. Low B12 equals high homocysteine
levels.
B12
absorption is dependent on several variables. Gastric acid
breaks down B12 that is bound to food. Intrinsic factor (from
the parietal cells in the stomach) binds to B12 in the duodenum.
It is this B12/Intrinsic factor complex that eventually gets
absorbed in the terminal ileum. There may be an alternate
source of absorption that is independent of intrinsic factor
or even an intact terminal ileum. This is why the old belief
that oral B12 supplementation could only occur with intrinsic
factor and a terminal ileum present is no longer true. Obviously
the interruption of any of these steps in the uptake may lead
to a B12 deficiency.
Diagnosis
is typically based on measurement of serum B12 levels. It
should be noted that about half of those with subclinical
disease have normal B12 levels. A more sensitive test for
screening may be measurement of serum methylmalonic acid and
homocysteine levels for reasons noted above. The use of a
Schilling test in pernicious anemia has been replaced in the
most part by serologic testing for Parietal cell and Intrinsic
factor antibodies. Remember that low folic acid levels can
result in low B12 levels as well.
Causes
of B12 deficiency include nutritional deficiency as B12 is
found in meat and diary products. The typical reserve in humans
is large and can maintain a patient for two to five years.
The elderly on a “tea and toast” diet may be at
high risk as are chronic alcoholics. Malabsorption syndromes
including autoimmune dysfunction and the body attacking parietal
cells account for most cases of pernicious anemia. The widespread
and prolonged use of H2 blockers and Proton Pump Inhibitors
for ulcer disease may cause impaired breakdown of B12 from
food rendering it unfit for absorption.
Supplementation
of B12 can be oral but in the past has been mostly through
IM injections. Now that we know that oral supplementation
is reliable the dosage of B12 supplementation is 1,000 to
2,000 mcg per day for one to two weeks followed by a maintenance
dosage of 1,000 mcg per day for life. IM injections have typically
been 100 to 1,000 mcg every day for one to two weeks followed
by a maintenance dosage of 100 to 1,000 mcg every one to three
months.
Follow
up should show an increase in reticulocytes if the treatment
is for anemia. This can be seen as early as one to two weeks
after start of therapy. In mild deficiency states usually
follow up includes rechecks of B12, homocysteine and methylmalonic
acid levels in two to three months after starting therapy.
1.
Robert C Oh, CPT MC USA, David L Brown, Maj MC USA. Vitamin
B12 Deficiency. Am Fam Physician 2003;67:979-86, 993-4.
GI011 Upper
and Lower GI bleeds
Gastrointestinal
bleeding is blood loss that comes from anywhere in the gastrointestinal
tract from the mouth to the anus. Bleeding is defined as upper
GI in origin if the source is proximal to the ligament of
Treitz. Bleeding distal to the ligament of Treitz is designated
as lower GI bleeding. Bleeding that is not symptomatic and
is found incidentally or with screening is defined as occult
GI bleeding. Occult bleeding may be either upper or lower
in origin, but in U.S. adults an upper source is more common.
Presentations
of upper GI bleeding include hematemesis (vomiting of red
or “coffee ground” blood) and melena (dark or
black stools). Though less common, 10% of patients presenting
with red blood per rectum will be found to have an upper GI
source. Lower GI bleeding presents most often as hematochezia
(blood mixed with stool) or purely as red blood per rectum.
In addition to the bleeding, patients should be evaluated
for signs and symptoms to help decide how severe the bleeding
is. Symptoms of orthostasis or dizziness, or signs of shock
(tachycardia, hypotension) indicate the severity of the bleed.
The
common causes of upper GI bleeding in order of frequency are:
1) Peptic ulcer disease
2) Portal hypertension (varicele bleeding)
3) Mallory-Weiss tears
4) Gastritis
5) Esophagitis
The
causes of major lower GI bleeding in order of frequency are:
1) Diverticulosis
2) Angiodysplasia
3) Neoplasms
4) Inflammatory bowel disease
5) Anorectal disease
Initial
evaluation includes a focused history and physical exam looking
for clues as to the etiology of the bleed and to try to determine
if it is upper or lower in origin. As part of the initial
evaluation, basic lab tests should be obtained including a
CBC, coagulation studies, a comprehensive metabolic panel,
and blood should be typed and cross-matched for 2-4 units
of blood. Vascular access should be secured with two 18 gauge
IV lines. Unless the patient’s complaint is bright red
blood per rectum, a nasogastric tube should be inserted and
aspiration of the gastric contents should be done looking
for red or coffee ground blood. An anorectal exam along with
a digital rectal exam and testing of stool for blood should
be done.
Volume
replacement and transfusion therapy are the mainstays of treatment.
Initial volume support should be with normal saline or lactated
ringers solution at a bolus dose of 20 ml/kg. If there are
signs or symptoms of shock, transfusion of packed red blood
cells should be done. In the face of acute bleeding, the hemoglobin
and hematocrit are not reliable indicators of volume status.
Transfusion of other blood products will depend on the clinical
picture. Platelet transfusion should be done for patients
with counts less than 50,000/?l. Patients with abnormal coagulation
studies, or who receive more than four units of packed RBCs
should be given fresh frozen plasma.
Medical
management of acute bleeding includes acid suppression medications
if an upper source is suspected. Proton pump inhibitors are
the preferred agents and should be given by the IV route.
To decrease the splanchnic blood flow and reduce portal pressure
in GI hemorrhage, a continuous IV infusion of octreotide (100µg
bolus followed by 50 µg/hr infusion) is recommended.
Acute
endoscopic management is recommended once the patient has
been hemodynamically stabilized. Endoscopy has three main
purposes:
1) To document the source of bleeding
2) To help determine the risk of re-bleeding
3) To render endoscopic therapy.
Endoscopic
therapy for upper GI bleeding includes vasoconstrictor injections
into bleeding sites, direct cauterization and band ligation
of varices. Injection and cautery treatments are also effective
for lower GI bleeding from diverticulosis or angiodysplasia.
1.
Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical
Diagnosis and Treatment. 44th Ed. McGraw-Hill. New York NY.
2005:533-540.
Close
Window. |